Periodic Reporting for period 1 - Finger Port (A non-invasive portable device that measures and tracks several physiological parameters in real-time to determine cardiovascular and health conditions)
Berichtszeitraum: 2018-12-01 bis 2019-03-31
The team is now working towards developing an upgraded Finger Port, increasing accuracy in detection of key CV parameters like continuous blood pressure, heart rate and pulse wave velocity. The key objectives of the development are to miniaturize the device, optimize the software to increase accuracy of extracted CV parameters and complete the optimisation of the data collection and management system including the user interface; transfer the production line to a Contract Manufacturing Organisation (CMO); execute a clinical validation, leading to CE Mark application; and finally, explore the reimbursement landscape across Europe to address the best approach for the most widespread market access.
The “Healthcare System challenge” is to find an intelligent and more effective way to enable CVDs monitoring and event prevention. In fact, specific preventive actions must be taken by healthcare systems in order to reduce such a high economic burden. Elfi-Tech addresses the challenge by guaranteeing timely and personalized treatment based on accurate and affordable, continuous, remote assessment of the patients’ cardiovascular conditions. For instance, in the case of high BP patients, this indication can be obtained only via daily measurements of the blood pressure. However, until now, physicians have only been able to accurately measure this parameter while the patient is at the hospital or at their offices, since daily home-based monitoring is often inaccurate.
The “Technological challenge” is to invent a safe method for taking accurate and continuous measurements of a set of cardiovascular parameters on a daily basis. Elfi-Tech’s concept has been to create a miniature, compact and wireless fingertip blood flow measurement device that can accurately transmit and track recorded data to an application available on PC, smartphone and tablet of both physicians and patients. Nowadays, existing solutions for CV monitoring present several drawbacks that reflect on healthcare systems and the people dealing with CVDs